Kara Cannon - Nov 23, 2022 Form 4 Insider Report for ENZO BIOCHEM INC (ENZ)

Role
Chief Operating Officer
Signature
/s/ Kara Cannon
Stock symbol
ENZ
Transactions as of
Nov 23, 2022
Transactions value $
$0
Form type
4
Date filed
11/28/2022, 05:26 PM
Previous filing
Jul 19, 2022
Next filing
Jan 31, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENZ Stock Option (to acquire Common Stock) Award $0 +200K $0.00 200K Nov 23, 2022 Common Stock 200K $1.97 Direct F1
holding ENZ Stock Option (to acquire Common Stock) 87.5K Nov 23, 2022 Common Stock 87.5K $2.98 Direct F2
holding ENZ Stock Option (to acquire Common Stock) 87.5K Nov 23, 2022 Common Stock 87.5K $3.36 Direct F2
holding ENZ Stock Option (to acquire Common Stock) 55.4K Nov 23, 2022 Common Stock 55.4K $2.63 Direct F2
holding ENZ Stock Option (to acquire Common Stock) 55.4K Nov 23, 2022 Common Stock 55.4K $2.20 Direct F2
holding ENZ Stock Option (to acquire Common Stock) 52K Nov 23, 2022 Common Stock 52K $2.80 Direct F2
holding ENZ Stock Option (to acquire Common Stock) 35K Nov 23, 2022 Common Stock 35K $4.42 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted 200,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 23, 2023.
F2 The stock options have a five-year term and will vest in three equal installments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.